Optiver Holding
MDGL icon

Optiver Holding’s Madrigal Pharmaceuticals MDGL Stock Holding History

Optiver Holding’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44
Closed -$23K – 2959
2026
Q1 		$23K Sell
44
-24
-35% -$11.5K ﹤0.01% 1076
2025
Q4 		$39.6K Sell
68
-68
-50% -$34.7K ﹤0.01% 932
2025
Q3 		$62.4K Buy
136
+18
+15% +$6.71K ﹤0.01% 751
2025
Q2 		$35.7K Buy
118
+31
+36% +$9.24K ﹤0.01% 689
2025
Q1 		$28.8K Buy
+87
New +$28.6K ﹤0.01% 607
2021
Q3 		– Sell
-1,072
Closed -$104K – 778
2021
Q2 		$104K Buy
+1,072
New +$127K ﹤0.01% 234

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Optiver Holding's MDGL Position: Q2 2026 in Review

Optiver Holding sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 44 shares — an estimated $23K sold.

Optiver Holding first reported a position in MDGL in Q2 2021 and held it in 6 quarters. The position peaked at $104K in Q2 2021. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Optiver Holding reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 44 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $23K.
  • Optiver Holding first reported a position in Madrigal Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Optiver Holding's Madrigal Pharmaceuticals position peaked at $104K in Q2 2021.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.